The "Minimal-Touch" Technique for Artificial Urinary Sphincter Placement: Description and Outcomes.


Journal

Urology research & practice
ISSN: 2980-1478
Titre abrégé: Urol Res Pract
Pays: Turkey
ID NLM: 9918608789006676

Informations de publication

Date de publication:
Jan 2023
Historique:
medline: 25 10 2023
pubmed: 25 10 2023
entrez: 25 10 2023
Statut: ppublish

Résumé

The study aimed to describe "minimal-touch" technique for primary artificial urinary sphincter placement and evaluate early device outcomes by comparing it with a historical cohort. We identified patients who underwent primary artificial urinary sphincter placement at our institution from 1983 to 2020. Statistical analysis was performed to identify the rate of postoperative device infection in patients who underwent minimal touch versus those who underwent our traditional technique. 526/2601 total procedures (20%) were performed using our "minimal-touch" approach, including 271/1554 patients (17%) who underwent primary artificial urinary sphincter placement over the study period. Around 2.3% of patients experienced device infection after artificial urinary sphincter procedures. In the "minimal-touch" era, 3/526 patients (0.7%) experienced device infection, including 1/271 (0.4%) of those with primary artificial urinary sphincter placement. In comparison, 46/2075 patients (2.7%) experienced device infection using the historical approach, with 29/1283 (2.3%) of primary artificial urinary sphincter placements resulting in removal for infection. Notably, 90% of device infections occurred within the first 6 months after primary placement. The difference in cumulative incidence of device infections at 12 months did not meet our threshold for statistical significance for either the total cohort of all AUS procedures (primary and revision) or the sub-group of only those patients undergoing primary artificial urinary sphincter placement (Gray K-sample test; P=.13 and .21, respectively). The "minimal-touch" approach for artificial urinary sphincter placement represents an easy-to-implement modification with potential implications on device outcomes. While early results appear promising, longer-term follow-up with greater statistical power is needed to determine whether this approach will lower the infection risk.

Identifiants

pubmed: 37877837
doi: 10.5152/tud.2023.22136
pmc: PMC10081129
doi:

Types de publication

Journal Article

Langues

eng

Pagination

40-47

Références

J Urol. 2012 Nov;188(5):1855-60
pubmed: 22999690
Scand J Urol. 2017 Aug;51(4):339-341
pubmed: 28580867
Neurourol Urodyn. 2019 Feb;38(2):710-718
pubmed: 30575997
Urology. 2017 May;103:179-184
pubmed: 28093308
Trials. 2018 Feb 21;19(1):131
pubmed: 29467024
J Urol. 1995 Aug;154(2 Pt 1):387-90
pubmed: 7609104
J Urol. 2016 Apr;195(4 Pt 1):1033-7
pubmed: 26518111
Urology. 2018 Mar;113:13-19
pubmed: 29031841
Transl Androl Urol. 2016 Oct;5(5):756-761
pubmed: 27785433
Investig Clin Urol. 2017 Jul;58(4):241-246
pubmed: 28681033
Can Urol Assoc J. 2016 Nov-Dec;10(11-12):405-409
pubmed: 28096915
J Sex Med. 2011 Jan;8(1):5-8
pubmed: 21199375
Am J Mens Health. 2018 Sep;12(5):1398-1402
pubmed: 27241681
J Urol. 2019 Jun;201(6):1152-1157
pubmed: 30707131
Urology. 2012 Jun;79(6):1310-5
pubmed: 22521187
J Urol. 2006 Sep;176(3):1008-11
pubmed: 16890680
Investig Clin Urol. 2016 Jan;57(1):3-13
pubmed: 26966721
Proc Inst Mech Eng H. 2014 Oct;228(10):1083-99
pubmed: 25406229
J Sex Med. 2017 Mar;14(3):455-463
pubmed: 28189561
J Urol. 2013 Apr;189(4):1437-43
pubmed: 23123374
Wounds. 2017 Jun;29(6):S1-S17
pubmed: 28682297
J Urol. 2008 Dec;180(6):2475-8
pubmed: 18930496
Eur Urol. 2013 Apr;63(4):681-9
pubmed: 23219375
J Urol. 2016 Sep;196(3):838-43
pubmed: 26997310
J Sex Med. 2016 Feb;13(2):270-6
pubmed: 26805939
J Urol. 2013 Jul;190(1):113-7
pubmed: 23313209
Int Braz J Urol. 2018 May-Jun;44(3):634-638
pubmed: 29412549
Sex Med Rev. 2016 Jul;4(3):294-300
pubmed: 27871962
Urology. 2018 Mar;113:220-224
pubmed: 29154982
Urology. 2015 Sep;86(3):602-7
pubmed: 26135815

Auteurs

Matthew J Ziegelmann (MJ)

Department of Urology, Mayo Clinic, Rochester, USA.

Kevin J Hebert (KJ)

Department of Urology, Mayo Clinic, Rochester, USA.

Brian J Linder (BJ)

Department of Urology, Mayo Clinic, Rochester, USA.

Laureano J Rangel (LJ)

Department of Health Sciences Research, Mayo Clinic, Rochester, USA.

Daniel S Elliott (DS)

Department of Urology, Mayo Clinic, Rochester, USA.

Classifications MeSH